Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Acute Liver Injury: early-phase trial registry

1 of 1 indexed Acute Liver Injury trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Acute Liver Injury: 1 US clinical trial tracked, 1 recruiting.

Acute Liver Injury is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), running 1 of these trials.

Enrollment posture brief

Registry condition acute-liver-injury

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Acute Liver Injury (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Acute Liver Injury

Acute Liver Injury lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Liver Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Liver Injury is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Acute Liver Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo for infusions Drug
1 trials
Placebo for prednisolone Drug
1 trials
Equine anti-thymocyte globulin Drug
1 trials
High-dose methylprednisolone Drug
1 trials
Prednisolone Drug
1 trials

US sites by state

Facility locations filed on Acute Liver Injury trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials
Missouri 1 trials
Massachusetts 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Liver Injury page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Liver Injury condition card totals 1 registered trials; most-linked intervention Placebo for infusions; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.